848 results on '"Panayi, G. S."'
Search Results
2. Immunotherapy
3. Genetic Factors in Rheumatoid Arthritis
4. HLA-DR4 Subtype Frequencies in Rheumatoid Arthritis Indicate that DRB1 is the Major Susceptibility Locus within the HLA Class II Region
5. Systemic gene transfer of binding immunoglobulin protein (BiP) prevents disease progression in murine collagen-induced arthritis
6. Corticotropin releasing hormone (CRH) promoter polymorphisms in various ethnic groups of patients with rheumatoid arthritis
7. Resolution-associated molecular patterns (RAMP): RAMParts defending immunological homeostasis?
8. Improved glycaemic control with disease remission in rheumatoid arthritis and hypoglycaemic effect of sulphasalazine
9. Irish society for rheumatology: Proceedings of annual general meeting held in Beaumont Hospital on Friday 22nd October, 1993
10. Irish association of rheumatology & rehabilitation: Proceedings of annual general meeting, Friday 6th November 1992 at St. Vincent’s Hospital, Elm Park, Dublin
11. Panel discussion on B cells and rituximab: mechanistic aspects, efficacy and safety in rheumatoid arthritis and non-Hodgkinʼs lymphoma
12. B cells: a fundamental role in the pathogenesis of rheumatoid arthritis?
13. Introduction
14. Irish association of rheumatology&rehabilitation: Proceedings of Annual General Meeting held November 1991
15. Proliferation of peripheral blood mononuclear cells from rheumatoid arthritis patients to mycobacterial antigens
16. Anti-BiP antibody levels in juvenile idiopathic arthritis (JIA)
17. Antibody response to the human stress protein BiP in rheumatoid arthritis
18. Differences in the postgraduate medical training system in rheumatology between the United Kingdom and Japan
19. BiP, a putative autoantigen in rheumatoid arthritis, stimulates IL-10-producing CD8-positive T cells from normal individuals
20. Third International Symposium for health professionals in rheumatology: Enschede 6–9 June 1990
21. Therapeutic Benefit of Blocking Interleukin-6 Activity With an Anti–Interleukin-6 Receptor Monoclonal Antibody in Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Trial
22. Repeat-cycle study of high-dose intravenous 4162W94 anti-CD4 humanized monoclonal antibody in rheumatoid arthritis. A randomized placebo-controlled trial
23. BLOCKING INTERLEUKING-6 (IL-6) BY AN ANTI-INTERLEUKIN-6 RECEPTOR (IL-6R) MONOCLONAL ANTIBODY IN RHEUMATOID ARTHRITIS (RA)
24. The role of TNF-α in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis (RA): a study using a human RA/SCID mouse chimera
25. Stromal Cell–Derived Factor 1 (CXCL12) Induces Monocyte Migration Into Human Synovium Transplanted Onto SCID Mice
26. Control of Rheumatoid Arthritis by Oral Tolerance
27. TNFα does not increase lymphocyte migration to fetal gut transplanted into severe combined immunodeficient (SCID) mice
28. Tumour necrosis factor-alpha (TNF-α) enhances lymphocyte migration into rheumatoid synovial tissue transplanted into severe combined immunodeficient (SCID) mice
29. CD8+,CD57+ T CELLS FROM HEALTHY ELDERLY SUBJECTS SUPPRESS NEUTROPHIL DEVELOPMENT IN VITRO: Implications for the Neutropenia of Felty’s and Large Granular Lymphocyte Syndromes
30. FIBROBLAST-LIKE SYNOVIOCYTES (FLS) INDUCE ANERGY IN T CELLS IN THE ABSENCE OF CD80 EXPRESSION
31. Cytokine Production in Felty’s Syndrome
32. EFFECTS OF INFLAMMATION AND TREATMENT ON BONE TURNOVER AND BONE MASS IN POLYMYALGIA RHEUMATICA
33. Immunological and Immune-Mediated Toxic Effects of Gold Compounds Used in the Treatment of Rheumatoid Arthritis
34. T CELL HYPOTHESIS IN RHEUMATOID ARTHRITIS (RA) TESTED BY HUMANISED NON-DEPLETING ANTI-CD4 MONOCLONAL ANTIBODY (mAb) TREATMENT I: SUPPRESSION OF DISEASE ACTIVITY AND ACUTE PHASE RESPONSE.: OGg379
35. T CELL HYPOTHESIS IN RHEUMATOID ARTHRITIS (RA) TESTED BY HUMANISED NON-DEPLETING ANTI-CD4 MONOCLONAL ANTIBODY (mAb) TREATMENT II: CLINICAL ACTIVITY IS RELATED TO PHARMACODYNAMIC EFFECTS.: OGg378
36. LIPOCORTIN DOES NOT MEDIATE THE INHIBITION OF ADHESION MOLECULE EXPRESSION INDUCED BY GLUCOCORTICOIDS.: T200
37. Reply: Severity of rheumatoid arthritis in Greek versus English patients: comment on the article by Drosos et al
38. Hematologic and Cytofluorographic Analysis of Patients with Felty's Syndrome: A Hypothesis that a Discrete Event Leads to Large Granular Lymphocyte Expansions in this Condition
39. Authors reply: Effect of gold treatment on cytokine expression in synovium
40. Human chimaeric antibody response in rheumatoid arthritis patients after treatment with a chimaeric anti-CD4 monoclonal antibody CM-T412
41. Treatment of rheumatoid arthritis with engineered human antibody to tumour necrosis factor alpha: CDP571
42. Autoantigens in rheumatoid arthritis
43. Genetic Basis Of Rheumatoid Disease: Hla Antigens, Disease Manifestations, And Toxic Reactions To Drugs
44. Circadian Variation In Disease Activity In Rheumatoid Arthritis
45. Pulse Treatment With Methylprednisolone In Rheumatoid Arthritis
46. Cytokine Induced Changes in the Endothelial Cell Surface Membrane: Significance for Lymphocyte Traffic in Inflammation
47. A Family Study of Gold-Induced Nephropathy in Patients with Rheumatoid Arthritis
48. Unified Concept Of Cell-Mediated Immune Reactions
49. Chairman’s Summary
50. Natural killer cell activity in inflammatory joint disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.